Guangdong Taienkang Pharmaceutical Co (SZSE:301263) Net Change in Cash : ¥59.7 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Guangdong Taienkang Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Guangdong Taienkang Pharmaceutical Co's Net Change in Cash for the three months ended in Mar. 2025 was ¥-57.6 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ¥59.7 Mil.

Guangdong Taienkang Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Guangdong Taienkang Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Taienkang Pharmaceutical Co Net Change in Cash Chart

Guangdong Taienkang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

13.90

44.12

669.17

-351.14

84.52

Guangdong Taienkang Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-32.72	78.59	-31.58	70.22	-57.58

Guangdong Taienkang Pharmaceutical Co Net Change in Cash Calculation

Guangdong Taienkang Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	89.333	+	66.259	+	-71.089	+	0.012
	=	84.5

Guangdong Taienkang Pharmaceutical Co's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -39.069 + -93.731 + 75.22 + 0.002

= -57.6

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥59.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Taienkang Pharmaceutical Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Guangdong Taienkang Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Taienkang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Taienkang Pharmaceutical Co Ltd (SZSE:301263) » Definitions » Net Change in Cash

Comparable Companies

SHSE:688276 SHSE:688091 SHSE:688131 SZSE:300401 SZSE:300119 SZSE:300363 SZSE:002332 SHSE:600789 SZSE:002275 SZSE:002737 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

N/A

Address

No. 8, Wanji South Second Street, Taishan North Road, Building A, Longhu District, Guangdong Province, Shantou, CHN, 515041

Website

http://www.tai-kang.com.cn

Guangdong Taienkang Pharmaceutical Co Ltd is engaged in the research and development, production, sales of pharmaceutical products, medical equipment, sanitary materials, and provision of medical-technical services and technology transfer.

Executives

Li Ting Directors, Directors, and Executives

Zhou Gui Xi Executives

Chen Chun Directors, executives

Guangdong Taienkang Pharmaceutical Co Headlines

No Headlines

Li Ting	Directors, Directors, and Executives
Zhou Gui Xi	Executives
Chen Chun	Directors, executives